Neuronetics (STIM)10% owner bought ~$117K

~$117K

Approx. value · 100K sh @ $1.17

10.6M

Holds after · shares reported

Traded

May 19, 2026

Filed

May 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 18, 2026Insider · 13 days before an 8-K10% owner purchased ~$820K of STIM shares in the open market
2. Mar 19, 2026Insider · 12 days before an 8-K10% owner purchased ~$599K of STIM shares in the open market
3. Mar 20, 2026Insider · 11 days before an 8-K10% owner purchased ~$239K of STIM shares in the open market
4. Mar 25, 2026Insider · 6 days before an 8-K10% owner purchased ~$175K of STIM shares in the open market
5. Mar 26, 2026Insider · 5 days before an 8-K10% owner purchased ~$36K of STIM shares in the open market
6. Mar 27, 2026Insider · 4 days before an 8-K10% owner purchased ~$675K of STIM shares in the open market
7. Mar 30, 2026Insider · 1 day before an 8-K10% owner purchased ~$482K of STIM shares in the open market
8. Mar 31, 2026Company filing · Form 8-K · Material agreement, RestructuringAnnounced job cuts, closures or a restructuring, and changed a top executive or board member (and 2 more items)“On March 31, 2026, Steven E. Pfanstiel, who has served as Executive Vice President, Chief Financial Officer, and Treasurer since July 15, 2025, informed the Company of his intention to resign on May 1, 2026.”
9. Apr 20, 2026Insider10% owner purchased ~$158K of STIM shares in the open market
10. Apr 21, 2026Insider · 14 days before results10% owner purchased ~$151K of STIM shares in the open market
11. May 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
12. May 12, 2026Insider · 6 days before an 8-K10% owner purchased ~$637K of STIM shares in the open market
13. May 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“(e) Neuronetics, Inc. (the “Company”) previously announced that the Board appointed Francis X. Brown III as the Company’s Interim Principal Financial and Accounting Officer (the “Interim PAO”) effective as of May 5, 2026 pursuant to an amended and restated consulting agreement with Mr. Brown dated as of April 22, 2026 (the “Interim PAO Consulting Agreement”).”
14. May 19, 2026 · this disclosureInsider10% owner purchased ~$117K of STIM shares in the open market

What came next

1. Jun 16, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 16, 2026, the board of directors of the Company (the “Board”) promoted Cory Anderson from the position of Senior Vice President, Chief Technology Officer to the position of Executive Vice President, General Manager of Greenbrook effective July 1, 2026 (the “Anderson Promotion Date”).”
2. Jul 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 17, 2026, Neuronetics, Inc. (the “Company”) and W. Andrew Macan, who has served as Executive Vice President, Chief Legal Officer, and Corporate Secretary and in various other similar capacities since January 21, 2020, entered into a Separation Agreement (the “Separation Agreement”).”
3. Jul 14, 2026Insider10% owner purchased ~$62K of STIM shares in the open market
4. Aug 11, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
5. Aug 11, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 11, 2026, in connection with Mr. Naor’s appointment (as described below), Francis X. Brown III’s appointment as Neuronetics, Inc.’s (the “Company”) interim principal financial and accounting officer ended.”
6. Aug 13, 2026Insider10% owner sold ~$321 of STIM shares in the open market
7. Aug 14, 2026Insider10% owner purchased ~$44K of STIM shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Neuronetics

For Neuronetics, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STIM page.

Other recent filings by Chernett Jorey, 10% owner

• SEC Form 4 at Neuronetics (STIM)Aug 17, 2026
• SEC Form 4 at Neuronetics (STIM)Aug 17, 2026
• SEC Form 4 at Neuronetics (STIM)Jul 15, 2026
• SEC Form 4 at Neuronetics (STIM)May 13, 2026
• SEC Form 4 at Neuronetics (STIM)Apr 22, 2026

The full history of Chernett Jorey, 10% owner is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Neuronetics

• SEC Form 4Aug 17, 2026
• SEC Form 4Aug 17, 2026
• SEC Form 4Jul 15, 2026
• SEC Form 4May 13, 2026
• SEC Form 4Apr 22, 2026
• SEC Form 4Apr 22, 2026

Everything OQRO holds on this company is on its STIM page.